Bayzed Health Group Inc (02609) published its Monthly Return for equity securities for November 2025, showing that the authorized share capital remained at 5,000,000,000 ordinary shares, each with a par value of USD 0.00001. The total authorized share capital remained USD 50,000, with no increase or decrease during the reporting period.

As of the end of November 2025, the number of issued shares stood at 1,318,466,823, unchanged from the previous month. No new share options were exercised, and there were no movements in treasury shares. The submission date of this report was 4 December 2025.